Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mirhojjat Khorasanizadeh, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Mahdaviani SA, Mansouri D, Jamee M, Zaki-Dizaji M, Aghdam KR, Mortaz E, Khorasanizadeh M, Eskian M, Movahedi M, Ghaffaripour H, Baghaie N, Hassanzad M, Chavoshzadeh Z, Mansouri M, Mesdaghi M, Ghaini M, Noori F, Eskandarzadeh S, Kahkooi S, Poorabdolah M, Tabarsi P, Moniri A, Farnia P, Karimi A, Boisson-Dupuis S, Rezaei N, Marjani M, Casanova JL, Bustamante J, Velayati AA. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients. J Clin Immunol. 2020 08; 40(6):872-882. PMID: 32602053.
    Citations:    
  2. Khorasanizadeh M, Eskian M, Camargo CA Jr., Rezaei N. Nutrition and Immunity Book; Chapter 2: Vitamin D and the Immune System. 2019; 15-51.
  3. Eskian M, Khorasanizadeh M, Zinzani PL, Illidge TM, Rezaei N. Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma. Int Rev Immunol. 2019; 38(2):79-91. PMID: 30931651.
    Citations:    
  4. Khorasanizadeh M, Yousefifard M, Eskian M, Lu Y, Chalangari M, Harrop JS, Jazayeri SB, Seyedpour S, Khodaei B, Hosseini M, Rahimi-Movaghar V. Neurological recovery following traumatic spinal cord injury: a systematic review and meta-analysis. J Neurosurg Spine. 2019 Feb 15; 1-17. PMID: 30771786.
    Citations:    
  5. Eskian M, Alavi A, Khorasanizadeh M, Viglianti BL, Jacobsson H, Barwick TD, Meysamie A, Yi SK, Iwano S, Bybel B, Caobelli F, Lococo F, Gea J, Sancho-Muñoz A, Schildt J, Tatci E, Lapa C, Keramida G, Peters M, Boktor RR, John J, Pitman AG, Mazurek T, Rezaei N. Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging. 2019 01; 46(1):224-237. PMID: 30350009.
    Citations:    
  6. Eskian M, Khorasanizadeh M, Assa'ad AH, Rezaei N. Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis. Clin Rev Allergy Immunol. 2018 Aug; 55(1):88-98. PMID: 29234969.
    Citations:    
  7. Eskian M, Khorasanizadeh M, Isidori A, Rezaei N. Radioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma. Int J Hematol Oncol. 2018 Mar; 7(1):IJH01. PMID: 30302233.
    Citations:    
  8. Eskian M, Khorasanizadeh M, Zinzani PL, Rezaei N. Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma. Immunotherapy. 2018 06; 10(8):699-711. PMID: 29569511.
    Citations:    
  9. Khorasanizadeh M, Eskian M, Vaccaro AR, Rahimi-Movaghar V. Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury. CNS Drugs. 2017 Nov; 31(11):911-937. PMID: 29063471.
    Citations:    
  10. Meysamie A, Salarvand F, Khorasanizadeh M, Ghalehtaki R, Eskian M, Ghodsi S, Ghalehtaki S, Abbasi M, Etemad K, Asgari F, Esteghamati A. Cardiovascular risk assessment by FRS and SCORE in Iranian adult population. J Diabetes Metab Disord. 2017; 16:35. PMID: 28852642.
    Citations:    
  11. Khorasanizadeh M, Eskian M, Rezaei N. Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma. Acta Med Iran. 2017 05; 55(5):352-353. PMID: 28724278.
    Citations:    
  12. Khorasanizadeh M, Eskian M, Gelfand EW, Rezaei N. Mitogen-activated protein kinases as therapeutic targets for asthma. Pharmacol Ther. 2017 Jun; 174:112-126. PMID: 28223227.
    Citations:    
  13. Chardoli M, Rezvani S, Mansouri P, Naderi K, Vafaei A, Khorasanizadeh M, Rahimi-Movaghar V. Is it safe to discharge blunt abdominal trauma patients with normal initial findings? Acta Chir Belg. 2017 Aug; 117(4):211-215. PMID: 27806680.
    Citations:    
  14. Eskian M, Khorasanizadeh M, Kraeber-Bodere F, Rezaei N. Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response. Crit Rev Oncol Hematol. 2016 Nov; 107:182-189. PMID: 27823646.
    Citations:    
  15. Khorasanizadeh M, Eskian M, Assa'ad AH, Camargo CA, Rezaei N. Efficacy and Safety of Benralizumab, a Monoclonal Antibody against IL-5Ra, in Uncontrolled Eosinophilic Asthma. Int Rev Immunol. 2016 07 03; 35(4):294-311. PMID: 27119985.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Khorasanizadeh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (66)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.